Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 217 clinical trials
None
VertiGO! - Get up and GO! With the Vestibular Implant

In the VertiGO! trial 8 participants with bilateral vestibulopathy (BV) and severe sensory neural hearing loss in the ear to be implanted will receive a combined cochlear (CI) and vestibular

  • 0 views
  • 05 Aug, 2021
  • 1 location
None
Minimally Invasive Vestibular Neurectomy Versus Tenotomy of the Stapedius and Tensor Tympani Muscles in the Management of Patients With Unilateral Meniere's Disease

The distinctive symptoms of Meniere's disease (MD) include recurrent vertigo spells, fluctuating hearing loss, aural fullness and tinnitus. Conservative treatment in MD comprises lifestyle

  • 0 views
  • 18 Jul, 2021
  • 1 location
None
Telephone Counseling in the Education of the Patient With Gastritis

patients with hearing loss, visual impairment, inability to understand / speak Turkish, who do not have a communication problem to prevent or prevent education or to participate in the study, who can

  • 0 views
  • 28 Jan, 2021
  • 1 location
None
Cost-effective Hearing Aid Delivery Models

compensate for their impaired hearing. Although OTC amplification devices are gaining popularity and are regarded as an important option for promoting accessible and affordable hearing healthcare, it

  • 101 views
  • 03 May, 2021
  • 2 locations
None
Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)

> Carbogen is a mixture of 5% CO2 with 95% O2. Carbogen is safe and it is used for the treatment of sudden sensory neural hearing loss or ocular ischemia. CO2 dilate cerebral arteriole and

  • 0 views
  • 29 May, 2021
  • 1 location
None
Hearing for Communication and Resident Engagement

Amplification is a well-established, evidence-based front-line treatment for those with impaired communication secondary to Age Related Hearing Loss (ARHL). ARHL is the most prevalent cause of

  • 6 views
  • 18 Jun, 2021
  • 1 location
None
Low-Dose Weekly vs High-Dose Cisplatin

This study is a prospective open-label randomized clinical trial. Following informed consent eligible LASCCHN patients (n=100) planned for CRT will be stratified by tumor p16 status and then randomized in a 1:1 fashion to either concurrent HD cisplatin or concurrent weekly LD cisplatin.

  • 0 views
  • 09 Sep, 2021
  • 3 locations
None
Ventilation Tube Insertion for Unilateral Meni re's Disease

The purpose of this trial is to assess the effects of transmyringeal ventilation tubes compared with sham-treatment which do not ventilate the middle ear, on the number of vertigo attacks lasting more than 20 minutes in participants with Menire's disease.

  • 0 views
  • 20 Oct, 2021
  • 1 location
None
Effect of Highly Bioavailable Curcumin on Subjective Tinnitus

This study will assess the effectiveness of highly bioavailable curcumin in suppressing subjective tinnitus based on pre- and post-treatment evaluations using the validated Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI) surveys.

  • 4 views
  • 25 Mar, 2021
  • 3 locations
None
Intranasal Dexmedetomidine for Sedated Hearing Testing

Auditory brainstem response testing is necessary in children who are not able to be tested by classical audiogram, because of their age or an associated retarded psycho-motor development or behavioral and cognitive troubles. This test needs a perfect immobility of the child, ideally being asleep. This situation is sometimes impossible …

  • 0 views
  • 25 Aug, 2021
  • 2 locations